NDC 69339-162

LUBIPROSTONE

Lubiprostone

LUBIPROSTONE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Dash Pharmaceuticals Llc. The primary component is Lubiprostone.

Product ID69339-162_10c7b62d-6c39-453c-8d9a-2f441725bc3b
NDC69339-162
Product TypeHuman Prescription Drug
Proprietary NameLUBIPROSTONE
Generic NameLubiprostone
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-10-17
Marketing CategoryNDA /
Application NumberNDA021908
Labeler NameDASH Pharmaceuticals LLC
Substance NameLUBIPROSTONE
Active Ingredient Strength8 ug/1
Pharm ClassesChloride Channel Activator [EPC], Chloride Channel Activators [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 69339-162-98

40 BLISTER PACK in 1 CARTON (69339-162-98) > 10 CAPSULE in 1 BLISTER PACK
Marketing Start Date2022-10-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LUBIPROSTONE" or generic name "Lubiprostone"

NDCBrand NameGeneric Name
0254-3028LubiprostoneLubiprostone
0254-3029LubiprostoneLubiprostone
0480-3479LubiprostoneLubiprostone
0480-4138LubiprostoneLubiprostone
10370-266LubiprostoneLubiprostone
10370-267LubiprostoneLubiprostone
42291-475LubiprostoneLubiprostone
42291-476LubiprostoneLubiprostone
43598-163LubiprostoneLubiprostone
43598-168LubiprostoneLubiprostone
55700-963LubiprostoneLubiprostone
63304-351Lubiprostonelubiprostone
63304-352Lubiprostonelubiprostone
65162-841LubiprostoneLubiprostone
65162-842LubiprostoneLubiprostone
69339-162LUBIPROSTONELUBIPROSTONE
69339-163LUBIPROSTONELUBIPROSTONE
35356-500Amitizalubiprostone
63629-6398Amitizalubiprostone
64764-080Amitizalubiprostone
64764-240Amitizalubiprostone
68151-5003Amitizalubiprostone
72189-410AmitzaLubiprostone

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.